SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended August 27, 202226, 2023

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 0-5109

 

MICROPAC INDUSTRIES, INC.

 

Delaware 75-1225149
(State or other jurisdiction of incorporation or organization)Incorporation) (I.R.S.IRS Employer Identification No.)
   

905 E. Walnut, Garland, Texas

 75040
(Address of Principal Executive Offices)Office) (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (972) 272-3571

 

Securities Registered Pursuant to Section 12(g) of the Act: common stock, par value $0.10.

Title of each classTrading
Symbol(s)
  Name of each exchange on which registered
Common Stock, $0.10 par value per shareMPADNONE

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of large accelerated filer,” accelerated filer,” smaller reporting company,” and emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer oEmerging growth company o

Accelerated filer

Non-accelerated filero

Smaller reporting company

x

Non-accelerated filer

o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

On October 11, 2022,10, 2023, there were 2,578,315 shares of Common Stock, $0.10 par value, outstanding.

 

MICROPAC INDUSTRIES, INC.

 

FORM 10-Q

 

August 27, 202226, 2023

 

INDEX

 

PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS3
Condensed Balance Sheets as of August 26, 2023 (unaudited) and November 30, 20223
Condensed Statements of Operations for the three and nine months ended August 26, 2023 and August 27, 2022 (unaudited)  4
Condensed Statements of Cash Flows for the nine months ended August 26, 2023 and August 27, 2022 (unaudited)5
Statements of Shareholders’ Equity for the three and nine months ended August 26, 2023 and August 27, 2022 (unaudited)6
Notes to Condensed Financial Statements (unaudited)7
ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS14
ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK17
ITEM 4 - CONTROLS AND PROCEDURES17
PART II - OTHER INFORMATION
ITEM 1 - LEGAL PROCEEDINGS17
ITEM 1A - RISK FACTORS17
ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS17
ITEM 3 - DEFAULTS UPON SENIOR SECURITIES17
ITEM 4 - MINE SAFETY DISCLOSURE17
ITEM 5 - OTHER INFORMATION17
ITEM 6 - EXHIBITS18
SIGNATURES18

PART I - FINANCIAL INFORMATION

 

ITEM 1 - FINANCIAL STATEMENTS

Condensed Balance Sheets as of August 27, 2022 (unaudited) and November 30, 2021

Condensed Statements of Operations for the three and nine months ended August 27, 2022 and August 28, 2021 (unaudited)

Condensed Statements of Cash Flows for the nine months ended August 27, 2022 and August 28, 2021 (unaudited)

Statements of Shareholders’ Equity for the three and nine months ended August 27, 2022 and August 28, 2021 (unaudited)

Notes to Condensed Financial Statements (unaudited)

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4 - CONTROLS AND PROCEDURES

PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

ITEM 1A -RISK FACTORS

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

ITEM 4 - MINE SAFETY DISCLOSURE

ITEM 5 - OTHER INFORMATION

ITEM 6 - EXHIBITS

SIGNATURES

PART I - FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

 

ITEM 1. FINANCIAL STATEMENTS

MICROPAC INDUSTRIES, INC.

CONDENSED BALANCE SHEETS

(Dollars in thousands)

 August 27, 2022 November 30, 2021
  (Unaudited)     
                
CURRENT ASSETS         August 26, 2023 November 30, 2022 
 (Unaudited)   
Cash and cash equivalents $15,602  $15,252  $11,449  $15,375 
Receivables, net of allowance for doubtful accounts of
$0 at August 27, 2022 and November 30, 2021
  3,610   4,974 
Receivables, net of allowance for doubtful accounts of
$0 at August 26, 2023 and November 30 2022
  3,288   3,644 
Other receivables  920        1,010   920 
Contract assets  912   603   623   408 
        
Inventories:                
Raw materials and supplies  5,928   5,738   7,198   6,715 
Work in process  3,641   2,946   4,921   3,573 
Total inventories  9,569   8,684   12,119   10,288 
Prepaid expenses and other assets  729   341   408   564 
Total current assets  31,342   29,854   28,897   31,199 
                
PROPERTY, PLANT AND EQUIPMENT, at cost:                
Land  1,518   1,518   1,518   1,518 
Buildings  498   498   21,013   498 
Facility improvements  1,126   1,126   1,126   1,126 
Furniture and fixtures  1,036   1,025   2,065   1,036 
Construction in process  18,616   8,019   153   19,415 
Machinery and equipment  9,844   9,390   10,173   9,952 
Total property, plant, and equipment  32,638   21,576   36,048   33,545 
Less accumulated depreciation  (10,985)  (10,739)  (11,707)  (11,082)
Net property, plant, and equipment  21,653   10,837   24,341   22,463 
Operating lease right to use asset  27   67   -   

14

 
Deferred income taxes, net  102   86 
Total assets $53,022  $40,758  $53,340  $53,762 
                
LIABILITIES AND SHAREHOLDERS’ EQUITY                
                
CURRENT LIABILITIES:                
Accounts payable $1,472  $1,963  $1,225  $1,173 
Accrued compensation  1,106   1,295   926   1,086 
Deferred revenue  1,155   1,258   560   1,192 
Property taxes payable  383   318   521   560 
Income tax payable  403   180   12   149 
Operating lease liabilities, current portion  27   53 
Short term debt  429   224 
Other accrued liabilities  28   25   24   47 
Total current liabilities  4,574   5,092   3,697   4,431 
                
Operating lease liabilities, less current portion       14 
Long Term Debt, net of debt issuance costs  14,359   3,369   15,417   14,535 
Deferred income taxes, net  20   16 
Total liabilities  18,953   8,491   19,114   18,966 
Commitments and contingencies                
                
SHAREHOLDERS’ EQUITY                
Common stock, $.10 par value, authorized
10,000,000 shares, 3,078,315 issued and
2,578,315 outstanding at August 27, 2022
November 30, 2021
  308    308 
Common stock, $.10 par value, authorized
10,000,000 shares, 3,078,315 issued and
2,578,315 outstanding at August 26, 2023
November 30, 2022
  308   308 
Additional paid-in-capital  885   885   944   885 
Treasury stock, 500,000 shares, at cost  (1,250)  (1,250)  (1,250)  (1,250)
Retained earnings  34,126   32,324   34,224   34,853 
Total shareholders’ equity  34,069   32,267   34,226   34,796 
Total liabilities and shareholders’ equity $53,022  $40,758  $53,340  $53,762 

 

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Dollars in thousands except share data)

(Unaudited)

 

                 
  Three months ended  Nine Months Ended 
  August 26, 2023  August 27, 2022  August 26, 2023  August 27, 2022 
             
             
NET SALES $6,458  $6,940  $20,091  $20,194 
                 
COST AND EXPENSES:                
                 
Cost of goods sold  (4,576)  (3,667)  (13,098)  (11,188)
                 
Research and development  (454)  (568)  (1,731)  (1,534)
                 
Selling, general & administrative expenses  (2,017)  (2,231)  (5,833)  (5,849)
                 
Total cost and expenses  (7,047)  (6466)  (20,662)  (18,571)
                 
OPERATING INCOME (LOSS)  (589)  474   (571)  1,623 
                 
Interest and other income, net  44   966   218   967 
                 
INCOME (LOSS) BEFORE TAXES  (545)  1,440   (353)  2,590 
                 
(Provision) benefit for taxes  15   (335)  (18)  (530)
                 
NET INCOME (LOSS) $(530) $1,105  $(371) $2,060 
                 
NET INCOME (LOSS) PER SHARE, BASIC AND DILUTED $(0.21) $0.43  $(0.14) $0.80 
                 
DIVIDENDS PER SHARE $-  $-  $0.10  $0.10 
                 
WEIGHTED AVERAGE OF SHARES, basic and diluted  2,578,315   2,578,315   2,578,315   2,578,315 

                 
  Three months ended Nine months ended
  August 27, 2022 August 28, 2021 August 27, 2022 August 28, 2021
         
         
NET SALES $6,940  $8,180  $20,194  $19,865 
                 
COST AND EXPENSES:                
                 
    Cost of goods sold  (3,667)  (4,407)  (11,188)  (11,237)
                 
    Research and development  (568)  (510)  (1,534)  (1,253)
                 
    Selling, general & administrative expenses  (2,231)  (1,649)  (5,849)  (4,628)
                 
                       Total cost and expenses  (6,466)  (6,566)  (18,571)  (17,118)
                 
OPERATING INCOME  474   1,614   1,623   2,747 
                 
Other income (expense), net  966   (210)  967   (190)
                 
INCOME BEFORE TAXES  1,440   1,404   2,590   2,557 
                 
    Provision for taxes  335   316   530   477 
                 
NET INCOME $1,105  $1,088  $2,060  $2,080 
NET INCOME PER SHARE, BASIC AND DILUTED $0.43  $0.42  $0.80  $0.81 
                 
DIVIDENDS PER SHARE $    $    $0.10  $0.10 
                 
WEIGHTED AVERAGE OF SHARES, basic and diluted  2,578,315   2,578,315   2,578,315   2,578,315 

 

See accompanying notes to financial statements.

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

         
  Nine months ended 
CASH FLOWS FROM OPERATING ACTIVITIES: August  26, 2023  

August 27, 2022

 
       
Net income (loss) $(371) $2,060 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Depreciation  650   297 
Stock-based compensation  59   - 
Amortization of debt issuance cost  38   - 
Deferred tax expense (benefit)  (16)  4 
Amortization of right of use assets  14   40 
Changes in certain current assets and liabilities:        
Decrease in accounts receivable  265   443 
Increase in contract assets  (215)  (309)
Increase in inventories  (1,831)  (884)
Increase (decrease) in prepaid expenses  157   (387)
Decrease in deferred revenue  (632)  (103)
Increase in accounts payable  29   328 
Decrease in accrued compensation  (159)  (189)
(Decrease) increase in income taxes payable  (138)  224 
Decrease in lease liabilities  (14)  (40)
(Decrease) increase in all other accrued liabilities  (47)  65 
         
Net cash (used in) provided by operating activities  (2,211)  1,549 
         
CASH FLOWS FROM INVESTING ACTIVITIES        
         
Additions to property, plant and equipment  (2,506)  (11,931)
         
Net cash used in investing activities  (2,506)  (11,931)
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Cash dividend  (258)  (258)
Proceeds from long term debt  1,222   10,990 
Payment on long term debt  (173)  - 
         
Net cash provided by financing activities  791   10,732 
         
Net increase (decrease) in cash and cash equivalents  (3,926)  350 
         
Cash and cash equivalents at beginning of period  15,375   15,252 
         
Cash and cash equivalents at end of period $11,449  $15,602 
         
Supplemental Cash Flow Disclosure:        
Cash paid for income taxes $177  $302 
Cash paid for interest $405  $373 
Supplemental Non-Cash Flow Disclosure:        
Changes in accrued property, plant, and equipment $22  $402 

 

         
  Nine months ended
  August  27, 2022 August  28, 2021
     
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income $2,060  $2,080 
Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation  297   290 
    Loss on disposal of equipment  —     232 
    Deferred tax expense  4   8 
    Amortization of right-of-use assets  40   37 
    Changes in certain current assets and liabilities:        
        Decrease (increase) in accounts receivable  443   (648)
        Increase in contract assets  (309)  (314)
        Decrease (increase) in inventories  (884)  251 
        Increase (decrease) in prepaid expenses  (387)  75 
        Increase in prepaid income taxes       223 
        (Decrease) increase in deferred revenue  (103)  32 
        Increase in accounts payable  328   664 
        (Decrease) increase in accrued compensation  (189)  107 
        Increase in income taxes payable  224   202 
        Decrease in lease liabilities  (40)  (37)
        Increase in all other accrued liabilities  65   105 
         
        Net cash provided by operating activities  1,549   3,307 
         
CASH FLOWS FROM INVESTING ACTIVITIES        

Additions to property, plant and equipment

  (11,931)  (3,363)
         
        Net cash used in investing activities  (11,931)  (3,363)
         

CASH FLOWS FROM FINANCING ACTIVITIES

        
         Cash dividend  (258)  (258)
         Proceeds from long term debt  10,990   71 
         
         Net cash provided by (used in) financing activities  10,732   (187)
         
Net increase (decrease) in cash and cash equivalents  350   (243)
         
Cash and cash equivalents at beginning of period  15,252   14,619 
         
Cash and cash equivalents at end of period $15,602  $14,376 
         
Supplemental Cash Flow Disclosure:        
         Cash paid for income taxes $302  $247 
Supplemental Non-Cash Flow Disclosure:        
         Changes in accrued property, plant, and equipment $402  $624 
         

See accompanying notes to financial statements.

 

MICROPAC INDUSTRIES, INC.

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE QUARTERS ENDED AUGUST 27, 202226, 2023 AND AUGUST 28, 202127, 2022

(Dollars in thousands)

(Unaudited)

                     
  Common  Additional  Treasury  Retained    
  Stock  paid-in-capital  Stock  Earnings  Total 
                
                
BALANCE, November 30, 2021 $308  $885  ($1,250) $32,324  $32,267 
                     
Dividend  -   -   -   (258)  (258)
Net income  -   -   -   464   464 
                     
BALANCE, February 26, 2022 $308  $885  ($1,250) $32,530  $32,473 
                     
Net income  -   -   -   491   491 
                     
BALANCE, May 28, 2022 $308  $885  ($1,250) $33,021  $32,964 
                     
Net income  -   -   -   1,105   1,105 
                     
BALANCE, August 27, 2022 $308  $885  ($1,250) $34,126  $34,069 

 

  Common Additional Treasury Retained  
  Stock paid-in-capital Stock Earnings Total
           
BALANCE, November 30, 2020 $308  $885  ($1,250) $29,524  $29,467 
                     
                                   Dividend  —     —     —     (258)  (258)
                                   Net loss  —     —     —     (301)  (301)
                     
BALANCE, February 27, 2021 $308  $885  ($1,250) $28,965  $28,908 
                     
                                   Net income  —     —     —     1,293   1,293 
                     
 BALANCE, May 29, 2021 $308  $885  ($1,250) $30,258  $30,201 
                     
                                   Net income  —     —     —     1,088   1,088 
                     
 BALANCE, August 28, 2021 $308  $885  ($1,250) $31,346  $31,289 
                     
   Common  Additional   Treasury   Retained     
   Stock  paid-in-capital   Stock   Earnings   Total 
                     
BALANCE, November 30, 2021 $308  $885  ($1,250) $32,324  $32,267 
                     
                                   Dividend  —     —     —     (258)  (258)
                                   Net income  —     —     —     464   464 
                     
BALANCE, February 26, 2022 $308  $885  ($1,250) $32,530  $32,473 
                     
                                   Net income  —     —     —     491   491 
                     
 BALANCE, May 28, 2022 $308  $885  ($1,250) $33,021  $32,964 
                     
                                   Net income  —     —     —     1,105   1,105 
                     
 BALANCE, August 27, 2022 $308  $885  ($1,250) $34,126  $34,069 

 

  Common  Additional  Treasury  Retained    
  Stock  paid-in-capital  Stock  Earnings  Total 
                
                
BALANCE, November 30, 2022 $308  $885  ($1,250) $34,853  $34,796 
                     
Dividend  -   -   -   (258)  (258)
Net loss  -   -   -   (56)  (56)
                     
BALANCE, February 26, 2023 $308  $885  ($1,250) $34,539  $34,482 
                     
Stock-based compensation      39   -   -   39 
Net income  -   -   -   215   215 
                     
 BALANCE, May 27, 2023 $308  $924  ($1,250) $34,754  $34,736 
                     
Stock-based compensation      20   -   -   20 
Net loss  -   -   -   (530)  (530)
                     
 BALANCE, August 26, 2023 $308  $944  ($1,250) $34,224  $34,226 

 

See accompanying notes to financial statements.

MICROPAC INDUSTRIES, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 BASIS OF PRESENTATION

 

Business Description

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space, medical and commercial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2015 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technologies are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

The Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 436434 shareholders on August 27, 2022.26, 2023.

 

In the opinion of management, the unaudited financial statements include all adjustments (consisting of only normal, recurring adjustments) necessary to present fairly the financial position as of August 27, 2022,26, 2023, the results of operations for the three and nine months ended August 27, 202226, 2023 and August 28, 202127, 2022 and the cash flows for the three and nine months ended August 27, 202226, 2023 and August 28, 2021,27, 2022, including the statement of shareholders equity. Unaudited financial statements are prepared on a basis substantially consistent with those audited for the year ended November 30, 2021.2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to the rules and regulations promulgated by the Securities and Exchange Commission. The Company’s fiscal year ends on the last day of November. The quarterly results end on the last Saturday of the quarter.

 

It is suggested that these financial statements be read in conjunction with the November 30, 20212022 Form 10-K filed with the SEC, including the audited financial statements and the accompanying notes thereto.

 

Note 2 SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

 

The Company's revenue on the majority of its customer contracts is recognized at a point in time, generally upon shipment of products.

 

To achieve that core principle, the Company applies the following steps:

 

1.Identify the contract(s) with a customer.

 

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space, medical and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

 

2.Identify the performance obligations in the contract.

 

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

 

3.Determine the transaction price.

 

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

 

4.Allocate the transaction price to the performance obligations in the contract.

 

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

 

5.Recognize revenue when (or as) the Company satisfies a performance obligation.

 

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

 

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

 

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed, and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

 

Disaggregation of Revenue

The following table summarizes the Company’s Net Salesnet sales by Product Line.product line.

  8/27/2022 8/28/2021
Microcircuits $5,585  $5,132 
Optoeletronics  6,056   5,144 
Sensors and Displays  8,553   9,589 
    Total Revenue $20,194  $19,865 
         
Timing of revenue recognition        
Transferred at a point in time $17,393  $19,039 
Transferred over time  2,801   826 
    Total Revenue $20,194  $19,865 

Schedule of net sales by product line        
  8/26/2023  8/27/2022 
Microcircuits $4,985  $5,585 
Optoeletronics  5,432   6,056 
Sensors and Displays  9,674   8,553 
  $20,091  $20,194 
         
Timing of revenue recognition:        
Transferred at a point in time $16,521  $17,393 
Transferred over time  3,570   2,801 
Total Revenue $20,091  $20,194 

The following table summarizes the Company’s Netnet sales by major market.

2023 Third Quarter Sales by Major Market.

 

           
2022 Third Quarter Sales by Major Market
Schedule of net sales by major market                    
 Military Space Medical Commercial  Total  Military Space Medical Commercial Total 
Domestic Direct $2,684  $317  $754  $401  $4,156  $3,312  $254  $489  $294  $4,349 
Domestic Distribution  2,101   278   0   156   2,535   1,444   81   7   313   1,845 
International  20   104   0   125   249   139   20   -   105   264 
 $4,805  $699  $754  $682  $6,940  $4,895  $355  $496  $712  $6,458 
                    
2021 Third Quarter Sales by Major Market
   Military    Space    Medical    Commercial    Total 
Domestic Direct $3,052  $971  $1,069  $149  $5,241 
Domestic Distribution  2,427   139   0   152   2,718 
International  25   120   0   76   221 
 $5,504  $1,230  $1,069  $377  $8,180 
                    
2022 Nine Months Sales by Major Market
   Military    Space    Medical    Commercial    Total 
Domestic Direct $8,322  $1,116  $2,138  $935  $12,511 
Domestic Distribution  5,485   996   —     629   7,110 
International  91   254   —     228   573 
 $13,898  $2,366  $2,138  $1,792  $20,194 
                    
2021 Nine Months Sales by Major Market
   Military    Space    Medical    Commercial    Total 
Domestic Direct $7,063  $2,141  $2,777  $437  $12,418 
Domestic Distribution  5,762   675   —     449   6,886 
International  152   255   —     154   561 
 $12,977  $3,071  $2,777  $1,040  $19,865 

 

2022 Third Quarter Sales by Major Market

  Military  Space  Medical  Commercial  Total 
Domestic Direct $2,684  $317  $754  $401  $4,156 
Domestic Distribution  2,101   278   -   156   2,535 
International  20   104   -   125   249 
  $4,805  $699  $754  $682  $6,940 

2023 Nine Months Sales by Major Market

  Military  Space  Medical  Commercial  Total 
Domestic Direct $7,618  $952  $2,275  $2,220  $13,065 
Domestic Distribution  4,318   910   -   737   5,965 
International  238   185   -   638   1,061 
  $12,174  $2,047  $2,275  $3,595  $20,091 

2022 Nine Months Sales by Major Market

  Military  Space  Medical  Commercial  Total 
Domestic Direct $8,322  $1,116  $2,138  $935  $12,511 
Domestic Distribution  5,485   996   -   629   7,110 
International  91   254   -   228   573 
  $13,898  $2,366  $2,138  $1,792  $20,194 

 

Receivables, net, Contract Assets and Contract Liabilities

 

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Condensed Balance Sheets. 

 

Receivables, net, contract assets and contract liabilities were as follows:

 

Receivables, net, Contract Assets and Contract Liabilities

(Dollars in thousands)

Schedule of receivables, net, contract assets and contract liabilities            
August 27, 2022 November 30, 2021 December 1, 2020 August 26, 2023 November 30, 2022 December 1, 2021 
Receivables, net$3,610  $4,974  $2,639  $3,288  $3,644  $4,974 
Contract assets$912  $603  $512  $623  $408  $603 
Deferred revenue$1,155  $1,258  $111  $560  $1,192  $1,258 

 

There was $103,000642,260 of revenue recognized in fiscal year 20222023 that was included in the deferred revenue liability balance at the beginning of the fiscal year.

 

Contract costs

 

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

 

Leases

 

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $165,000for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $14,000 for the first nine months of 2023 and $40,000 for the first nine months of 2022 and $37,000 for the first nine months of 2021.2022. The Company used an estimated incremental borrowing rate of 3.253.25%% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is six months.

The Undiscounted Future Minimum Lease Payments consist of the following at:

    8/27/2022 
2022  $14,000 
2023   14,000 
Total lease payments   28,000 
Interest   1,000 
Present value of lease liabilities  $27,000 
      

Short-Term Investmentsexpired in March 2023 and was not renewed.

 

The Company had no short-term investments at August 27, 2022 or November 30, 2021. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

Inventories

 

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

 

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained.  The Company did notnot record any liability for uncertain tax positions as of August 27, 202226, 2023 or November 30, 2021.2022.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

    
Buildings.........................................................................................................................................................1530
Facility improvements.........................................................................................................................................................815
Machinery and equipment.........................................................................................................................................................510
Furniture and fixtures.........................................................................................................................................................58

Schedule of property,plant and equipment useful lives
Buildings15-39
Facility improvements8-15
Machinery and equipment5-10
Furniture and fixtures5-8

 

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

 

Construction in progress relates to multiple capital projects ongoing during the year ended November 30, 20212022 and the nine months ended August 27, 2022,26, 2023, including the construction of the new manufacturing facility. Construction in progress also includes interest and fees on debt that are directly related to the financing of the Company’s capital projects. In March 2023, the new manufacturing facility was completed and placed in service.

 

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

 

Research and Development Costs

 

Costs for the design and development of new products are expensed as incurred.

 

Basic and Diluted Earnings Per Share

 

10 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted

The following is a reconciliation of the number of shares used in the calculation of the basic and diluted earnings per share gives effect to all dilutive potential common shares. Forfor the three and nine months ended August 27, 202226, 2023 and August 28, 2021,27, 2022:

Schedule of the basic and diluted earnings per share                
  Three months ended  Nine Months Ended 
  August 26, 2023  August 27, 2022  August 26, 2023  August 27, 2022 
             
Weighted average of shares, basic  2,578,315   2,578,315   2,578,315   2,578,315 
Restricted stock units  -   -   -   - 
Weighted average of shares, diluted  2,578,315   2,578,315   2,578,315   2,578,315 

Due to the current loss position, the Company had no dilutive potential commonhas not included the 35,650 restricted stock instruments.units due to being anti-dilutive in nature.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Note 3 NEW ACCOUNTING PRONOUNCEMENTS

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 20221, 2023 for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

 

Note 4 FAIR VALUE MEASUREMENT

 

The Company had no financial assets or liabilities measured at fair value on a recurring basis as of August 27, 202226, 2023 or November 30, 2021.2022.  The fair value of financial instruments such as cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.

 

The Company measures its long-term debt at fair value, which approximates book value as the long-term debt bears market rates of interestinterest.

 

There were no nonfinancial assets measured at fair value on a nonrecurring basis August 27, 202226, 2023 and November 30, 2021.2022.

 

Note 5 COMMITMENTS

 

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement (the “loan agreement”) with Frost Bank (“Frost”) (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.403.40%%) per annum.

 

On March 26, 2021, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.”. The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate with a floor of 3.253.25%%. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the Company as borrower and Frost as lender.  

 

Construction Loans.  Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.$16,160,000.

 

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

 

The interest rate of (3.40%(3.40%) per annum includingincludes an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the

11 

unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

 

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2 acre tract in Garland, Texas and the improvements made on it.

 

Revolving Credit Loans.  Subject to the terms of the, Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000,$6,000,000, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement. There are no borrowings outstanding as of August 26, 2023. The loan has a maturity date of April 23, 2023.2025.

 

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

 

The Company has borrowed $14,538,00016,160,000 against the construction loan as of August 27, 2022.26, 2023. 

Schedule of long-term debt    

Debt August 26, 2023

  
Notes payable $15,987,000 
Less unamortized debt issuance costs  141,000 
Net Debt  15,846,000 
Less—Current portion  429,000 
Total long-term debt $15,417,000 

 

Estimated maturities of our long-term debt over the next 5 years are as follows:

Debt  August 27, 2022 
Notes payable $14,538,000 
Less unamortized debt issuance costs  179,000 
Net Debt  14,359,000 
Less—Current portion  —   
Total long-term debt $14,359,000 

Estimated maturities of long-term debt                     
  2023  2024  2025  2026  2027  Thereafter  Total 
Frost Bank $106  $433  $447  $463  $479  $14,059  $15,987 

 

Note 6 EARNINGS PER COMMON SHARE

 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three and nine months ended August 27, 2022 and August 28, 2021,26, 2023, the Company had nohas dilutive potential common stock instruments.instruments with the restricted stock units.

 

Note 7 SHAREHOLDERS’ EQUITY

On December 7, 2022, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2023. The dividend was paid to shareholders on February 10, 2023.

 

On December 7, 2021, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2022. The dividend was paid to shareholders on February 10, 2022.

 

OnNOTE 8 December 8, 2020STOCK-BASED COMPENSATION, the Board of Directors

We have issued restricted stock units ("RSUs") stock-based compensation awards as part of Micropac Industries Inc. approved’s 2023 Equity Incentive Plan. Our 2023 annual grant of RSUs occurred in the paymentsecond quarter. The weighted -average grant-date fair value of each unit granted in 2023 was $13.13. All the RSUs granted in 2023 vest over a $0.10 per share special dividend to all shareholders of record as of January 6, 2021. The dividend was paid to shareholders on February 12, 2021.

Note 8 EMPLOYEE RETENTION CREDIT UNDER THE CARES ACTthree-year period.

 

The CARES Act, passed by Congress on Marchfollowing is a summary of our RSUs activity for nine months ended August 26, 2023 and August 27, 2020, contained2022:

Schedule of restricted stock units activity                
  2023  2022 
(shares in thousands) Number
of
Shares
  Weighted-
Average
Grant Date Fair
Value
  Number
of
Shares
  Weighted-
Average
Grant
Date Fair
Value
 
Unvested at beginning of period  -   -   -   - 
Granted  35.7  $13.13   -   - 
Vested  -   -   -   - 
Cancelled  -   -   -   - 
Unvested at end of the period  35.7  $13.13   -   - 

The following table sets forth the employee retention credit (ERC), a refundable payroll tax credit to employers that have experienced hardshipstock-based compensation expense recorded in their operations due to COVID-19. The CARES Act was amendedselling, general and extended on December 27, 2020 by the Consolidated Appropriations Act, 2021 (the “CAA”administrative ("SG&A") and in March 2021, the Internal Revenue Code was amended by the American Rescue Plan Act of 2021 to provide new employee retention credit provisions designed to promote employee retention and hiring.expense (in thousands): 

Schedule of stock-based compensation   
  August 26, 2023 and August 27, 2022 
  Three Months Ended  Nine Months Ended 
  2023  2022  2023  2022 
Stock-based compensation expense $20.00   -  $59.00   - 

 

This ERC is a fully refundable tax credit for employers equalThe following table sets forth the stock-based unvested compensation expense by year to 70 percent of qualified wages that eligible employers pay their employees. This ERC applies to qualified wages paid after December 2020 and before January 1, 2022.be recognized (in thousands):

 

As a result, the Company has determined that it qualified for a $920,299 in employee retention credits during the first quarter of 2021, which the Company recognized as other income and recorded in other receivables for the refund claimed in the third quarter of 2022. The ERC impact was included in the Company’s fiscal year 2021 tax return.

12 
Schedule of stock-based unvested compensation expense 2023  2024  2025  Total 
Stock-based unvested compensation expense  20   78   78   176 

 

MICROPAC INDUSTRIES, INC.

(Unaudited)

 

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Business

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

Critical Accounting Policies

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions and factors that are believed to be reasonable under the circumstances. Note 2 to the Financial Statements in the Quarterly Report Form 10-Q for the quarter ended August 27, 2022,26, 2023, describes the significant accounting policies and methods used in the preparation of the Financial Statements. Actual results could differ from these estimates.

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company’s revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products. The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion in order to determine the amount of consideration earned for contractual revenue recognized over time.

 

The allowance for doubtful accounts is based on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than our historical experience, our estimates of the recoverability of amounts due us could be adversely affected.

 

Inventory purchases and commitments are based upon future demand. If there is a sudden and significant decrease in demand for our products or there is a higher risk of inventory obsolescence because of changing customer requirements, we may be required to increase our inventory allowances and our gross margin could be adversely affected.

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. If we were to determine we would not be able to realize all or part of the deferred tax asset in the future, an adjustment to the deferred tax asset would be necessary which would reduce our net income for that period.

 

13 

Depreciable and useful lives estimated for property and equipment are based on initial expectations of the period of time these assets will provide benefit. Changes in circumstances related to a change in our business or other factors could result in these assets becoming impaired, which could adversely affect the value of these assets

 

Results of Operations

  Three months ended Nine months ended
   8/27/2022   8/28/2021   8/27/2022   8/28/2021 
NET SALES  100.0%  100.0%  100.0%  100.0%
                 
COST AND EXPENSES:                
    Cost of Goods Sold  52.9%  53.9%  55.4%  56.6%
    Research and development  8.2%  6.2%  7.6%  6.3%
    Selling, general & administrative expenses  32.1%  20.2%  29.0%  23.3%
                                    Total cost and expenses  93.2%  80.3%  92.0%  86.2%
                 
OPERATING INCOME BEFORE INTEREST AND INCOME TAXES  6.8%  19.7%  8.0%  13.8%
                 
    Interest and other income  13.9%  (2.6%)  4.8%  (0.9%)
                 
INCOME BEFORE TAXES  20.7%  17.2%  12.8%  12.9%
                 
    Provision for taxes  4.7%  3.9%  2.6%  2.4%
                 
NET INCOME  16.0%  13.3%  10.2%  10.5%

 

      Three months ended  Nine months ended 
   8/26/2023   8/27/2022   8/26/2023   8/27/2022 
NET SALES  100.0%  100.0%  100.0%  100.0%
                 
COST AND EXPENSES:                
Cost of Goods Sold  70.8%  52.9%  65.2%  55.4%
Research and development  7.0%  8.2%  8.6%  7.6%
Selling, general & administrative expenses  31.2%  32.1%  29.0%  29.0%
Total cost and expenses  109.0%  93.2%  102.8%  92.0%
                 
OPERATING INCOME (LOSS)  (9.0%)  6.8%  (2.8%)  8.0%
                 
Interest and other income, net  0.7%  13.9%  1.0%  4.8%
                 
INCOME (LOSS) BEFORE TAXES  (8.3%)  20.7%  (1.8%)  12.8%
                 
(Provision) benefit for taxes  0.2%  (4.7%)  (0%)  (2.6%)
                 
NET INCOME (LOSS)  (8.1%)  16.0%  (1.8%)  10.2%

Sales for the three and nine month periods ended August 27, 202226, 2023 totaled $6,940,000$6,458,000 and $20,194,000,$20,091,000, respectively. Sales for the third quarter decreased $1,240,000$482,000 from the same period of 20212022 while sales for the first nine months of 2022 increased $329,0002023 decreased $103,000 from the first nine months of 2021.2022. The majority of the decrease for the three months ended August 27, 202226, 2023 is related to timing of shipments of customer orders of custom sensorstandard solid state relays products. Sales were 18% in the commercial market, 11% in the medical market, 61% in the military market, and 10% in the space market for the nine months ended August 26, 2023 compared to 9% in the commercial market, 10% in the medical market, 69% in the military market, and 12% in the space market for the nine months ended August 27, 2022 compared to 5% in2022.

Three customers accounted for 13%, 11%, and 10% of the commercial market, 14% inCompany’s sales for the medical market, 66% in the military market,three months ended August 26, 2023, and 15% in the space markettwo customers accounted for 12% and 10% for the nine months ended August 28, 2021.

One26, 2023, while one customer accounted for 18% of the Company’s sales for the three months ended August 27, 2022, and two customers accounted for 17% and 10% for the nine months ended August 27, 2022, while one customer accounted for 21% and 20% of the Company’s sales for the three months and nine months ended August 28, 2021.2022.

 

Cost of goods sold for the third quarters of 2023 and 2022 totaled 70.8% and 2021 totaled 52.9% and 53.9% of net sales, respectively, while cost of goods sold for the nine months ended August 26, 2023 and August 27, 2022 totaled 65.2% and August 28, 2021 totaled 55.4% and 56.6% of net sales, respectively. In actual dollars, cost of goods sold decreased $740,000increased $909,000 in the third quarter of 20222023 compared to the same period of 2021.2022. Year to date cost of goods sold decreased $49,000increased $1,910,000 for the first nine months of 20222023 as compared to the same period in 2021.2022. Most of the increase in cost of goods sold was an increase in material cost on a custom product for a customer during the engineering and first production builds resulting in lower gross margins. The contract with the customer on the custom product has been completed. In addition, depreciation expense increased associated with the new facility being placed into service.

 

Research and development expense increased $58,000decreased $114,000 for the third quarter of 20222023 versus 20212022 and increased $281,000$197,000 for the first nine months of 20222023 compared to the same period of 2021.2022. The research and development expenditures were associated with continued development of several power management products and fiber optic transceivers and high voltage optocouplers.transceivers. The Company will continue to invest in research and development of these products and other new opportunities.

 

Selling, general and administrative expense for the third quarter and first nine months of 20222023 totaled 32.1%31.2% and 29.0% respectively of net sales compared to 20.2%32.1% and 23.3%29.0% for the same periods in 2021.2022. In actual dollars, selling, general and administrative expense increased $582,000decreased $214,000 for the third quarter and increased $1,221,000decreased $16,000 for the first nine months of 20222023 compared to the same periods in 2021.2022. The majority of the

14 

increase decrease for the first ninethree months ended August 26, 2023 resulted from an increasedecrease in commission expense in 2022, property tax on the new building and consultant fees.

 

Provisions for taxes increased $19,000decreased $350,000 for the third quarter of 20222023 and increased $53,000decreased $512,000 for the first nine months of 20222023 compared to the same period in 2021. The estimated effective tax rate was 20% for 2022 and 18% for 2021.2022.

 

Net income increased $17,000decreased $1,635,000 for the third quarter of 20222023 versus 20212022 and decreased $20,000$2,431,000 for the first nine months of 20222023 compared to the same period of 2021.2022.

 

Liquidity and Capital Resources

 

The Company will useused a combination of cash and a commercial real estate construction loan for the construction of a the new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas the Company purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan as discussed in Note 5 to the condensed financial statements.

 

As of August 27, 2022,26, 2023, the Company has $18,616,000 in construction in process on the new facility and has $14,538,000$15,987,000 in notes payable on the construction loan, outstanding draw request of $128,000 in account payables and has used $2,515,000 of the Company’s cash.loan. In addition, the Company has unamortized loan fees on the construction loan in the amount of $179,000.$141,000.

In addition, the Company continues on-going investigations for the use of cumulative cash for business expansion and improvements, such as operational improvements and new product expansion.

 

Cash and cash equivalents totaled $15,602,000$11,449,000 as of August 27, 202226, 2023 compared to $15,252,000$15,375,000 on November 30, 2021,2022, an increasedecrease of $350,000.$3,926,000. The increasedecrease in cash and cash equivalents is attributable to $1,549,000$2,249,000 cash provided byused in operations, $10,990,000 proceeds from the construction loan, offset by the payment of a cash dividend of $258,000, $504,000$223,000 in cash for additional manufacturing equipment and $11,427,000$2,283,000 for construction in process onof the new facility.facility offset by $1,087,000 net proceeds from the financing

 

In addition to cash on hand, the Company also has the ability to borrow under a loan agreement as discussed in Note 5 to the condensed financial statements.

 

The Company has no significant off-balance sheet arrangements.

 

Outlook

 

New orders for year-to-date 20212023 totaled $19,792,000$29,349,000 compared to $23,568,000$19,792,000 for 2022. The increase resulted from timing of new orders for several custom products.$8,432,000 in space level solid state relays.

 

Backlog totaled $42,718,000 on August 26, 2023 compared to $36,421,000 onas of August 27, 2022 compared to $29,943,000 as of August 28, 2021 and $32,635,000$32,686,000 on November 30, 20212022 and represents a good mix of the company’s products and technologies.

 

2022 Current Backlog by Major Market
2023 Current Backlog by Major Market2023 Current Backlog by Major Market
 Military Space Medical Commercial Total Military Space Medical Commercial Total 
Domestic Direct $15,351  $2,595  $6,381  $1,853  $26,180  $19,962  $841  $2,259  $1,364  $24,426 
Domestic Distribution  8,113   703   —     448   9,264   13,886   1,829   -   1,056   16,771 
International  277   120   —     580   977   372   706   -   443   1,521 
 $23,741  $3,418  $6,381  $2,881  $36,421  $34,220  $3,376  $2,259  $2,863  $42,718 

 

2022 Current Backlog by Product Line
2023 Current Backlog by Product Line2023 Current Backlog by Product Line
Microelectronics $12,449  $22,195 
Optoelectronics  5,658   5,745 
Sensors and Displays  18,314   14,778 
 $36,421  $42,718 

 

The Company cannot assure that the results of operations for the interim period presented are indicative of total results for the entire year due to fluctuations in customer delivery schedules, or other factors over which the Company has no control.

 

15 

Impact of COVID-19 on our Business

 

In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic.

The Company continues to monitor our supply chain and orders from customers for COVID-19 pandemic related changes. We are continuing to serve our customers while taking precautions to provide a safe work environment for our employees and customers. We have been staggering some shifts and otherwise adjusting work schedules to maximize our capacity while adhering to recommended precautions. We have established and implemented a work from home provision where possible.

 

To date, we have not experienced significant raw material shortages; however, supply-chain disruptions could potentially delay or prevent us from fulfilling customer orders.

 

Cautionary Statement

 

This Form 10-Q contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially. Investors are warned that forward-looking statements involve risks and unknown factors including, but not limited to: our expectations regarding the potential impacts on our operations of the COVID-19 pandemic; our expectations regarding the potential impacts on our supply chain and on our customers of the COVID-19 pandemic; overall changes in governmental spending for military and space programs; customer cancellation or rescheduling of orders, problems affecting delivery of vendor-supplied raw materials and components, unanticipated manufacturing problems and availability of direct labor resources.

 

The Company does not intend to update the forward-looking statements contained herein, except as may be required by law.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable

 

ITEM 4.CONTROLS AND PROCEDURES

 

(a)Evaluation of disclosure controls and procedures.

 

The Chief Executive Officer and Chief Financial Officer of the Company evaluated the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15) as of August 27, 202226, 2023 and, based on this evaluation, concluded that the Company’s disclosure controls and procedures are functioning in an effective manner to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.

 

(b)Changes in internal controls.

 

There has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting during the threenine month period ended August 27, 2022.26, 2023.

 

 

PART II - OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

The Company is not involved in any material current or pending legal proceedings.

 

ITEM 1ARISK FACTORS

 

Information about risk factors for the three and nine months ended August 27, 202226, 2023 does not differ materially from that set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended November 30, 20212022

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None

 

16 
ITEM 4.MINE SAFETY DISCLOSURE

 

Not Applicable

 

ITEM 5.OTHER INFORMATION

 

None

 

ITEM 6.EXHIBITS

 

(a)        Exhibits

 

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

32.2

Certification of Chief Accounting Officer pursuant to 18 U. S. C. section 1350,as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

 

 

SIGNATURES

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

 

 

 

MICROPAC INDUSTRIES, INC.

 

 

 

October 11, 2022 
October 10, 2023/s/ Mark King
DateMark King 
Mark KingChief Executive Officer
  Chief Executive Officer

October 11, 2022/s/ Patrick Cefalu
DatePatrick Cefalu
  
October 10, 2023/s/ Patrick Cefalu
DatePatrick Cefalu
Chief Financial Officer

18